• Increase font size
  • Default font size
  • Decrease font size

Cyber reporter kept fellow investors informed during Hemispherx meeting

Print E-mail
By M.E.Garza   
Thursday, 25 June 2009 21:12

BioMedReports.com - Cyber reporter kept fellow investors informed during Hemispherx meetingJim "Griz" Adams reported from the Hemispherx Biopharma's shareholders meeting using little more than his laptop and an internet connection.

Employing his on-line alias, "StarmanDSS," Adams was able to provide fellow investors on social media forums like the YahooFinance boards with a much anticipated trickle of information that helped soothe nerves, kill rumors and ultimately gave many investors renewed confidence in the company.

As of this moment, the company, it's shareholders and CFS patients continue to anxiously await a long delayed FDA's decision to clear Ampligen(R) as a treatment for Chronic Fatigue Syndrome.

Shares of Hemispherx Biopharma traded up almost 20% and the company was among the biggest gainers in healthcare on Thursday.

Below is an audio interview full of information and intelligence that might not otherwise be available elsewhere to HEB investors.  In it, Mr. Adams shares with us an inside look at what transpired in Philadelphia on Wednesday.

 

Disclosure: Adams is long HEB





BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 
about 2 hours ago A Stem-Cell-Based Drug Gets Approval in Canada $OSIR http://t.co/XI3gAfMY
about 3 hours ago $JNJ Zytiga, a Prostate Cancer Drug, Does Well in Trial http://t.co/v7YUm9b6
about 4 hours ago $PFE Pfizer Lung Drug Stops Deadly Child Cancers in Study | http://t.co/hcfdrnCY
about 5 hours ago Human Genome Looks to Anyone but GlaxoSmithKline | http://t.co/d4IMkIn3
about 6 hours ago When David Einhorn did not mention Herbalife $HLF as a potential short candidate, that stock shot up on Wednesday | http://t.co/XpFKihQS
about 7 hours ago Stock Market: Stocks Get Hammered On Disappointing Data, Greece Worries http://t.co/FyH8zpru
about 7 hours ago Synergy Pharmaceuticals (SGYP) May Be Ready To Roll - Small Cap Stock Market Investing Tips http://t.co/FHYXlF1Q
about 10 hours ago Alvine Presents Results from Phase 2A Trial of ALV003 in Celiac Disease Patients -2012 Digestive Diseases Week Meeting http://t.co/e6Rjhbj9

navigation

Free Phone Trade Alerts

Benzinga.com supporter Seeking Alpha Certified